FDA issued a Warning Letter to California Pharmacy & Compounding Center on 6/17/2015 for a previous inspection.
483 California Pharmacy & Compounding Center Apr 2017

483 California Pharmacy & Compounding Center Apr 2017

Darren Brown FDA$119.00 - Available Now

FDA investigators audited the California Pharmacy & Compounding Center - Newport Beach, CA, United States facility and issued 7 inspectional observations (via FDA 483) on 21 Apr 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 7
  • Inspection end: 21 Apr 2017
  • Location: Newport Beach, United States
  • FEI: 3004600090
Add To Cart